ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. Ginkgo Biloba versus Desmopressin in Tre…

Ginkgo Biloba versus Desmopressin in Treatment of Children with Monosymptomatic Nocturnal Enuresis: A Randomized Controlled Trial

Journal of Pediatric Urology·June 9
PediatricsLimited evidenceMonosymptomatic Nocturnal EnuresisRandomized Controlled TrialHerbal SupplementSynthetic Vasopressin AnaloguePediatricDesmopressinGinkgo Biloba

Summary

View source

What was studied

This RCT compared Ginkgo biloba to desmopressin for treating monosymptomatic nocturnal enuresis (MNE) in children, evaluating efficacy across a defined treatment timeframe.

Key findings

The study reports comparative outcomes between Ginkgo biloba and desmopressin in reducing bedwetting episodes in children with MNE, though specific numerical results are not available from the provided abstract.

Study limitations

Only the paper metadata was provided — no abstract, methods, results, or discussion text is available to extract specific findings, sample size, or limitations.

Clinical implications

Clinicians should await full-text review before drawing conclusions about Ginkgo biloba as an alternative to desmopressin in pediatric MNE, as detailed efficacy and safety data are not yet extractable from available information.

Related Questions

Explore related topics

What is the current evidence for desmopressin in treating monosymptomatic nocturnal enuresis in children?Are there effective non-pharmacological or herbal treatments for pediatric bedwetting?How does Ginkgo biloba work as a potential treatment for enuresis in children?

Publication Details

Year
2026
Journal
Journal of Pediatric Urology
Source
View article
Keep scrolling
More content below.
Up Next